The role of mucociliary dysfunction in bronchial asthma

Area of Science:

• Respiratory Medicine
• Pulmonology
• Cellular Biology

Background:

• Clinical observations suggest impaired mucociliary function in bronchial asthma patients, characterized by excessive tracheobronchial secretions.
• Difficult expectoration of mucus can contribute to airway obstruction in asthma.
• Previous studies indicate impaired mucociliary transport mechanisms, but the underlying pathogenesis remains unclear.

Purpose of the Study:

• To investigate the abnormalities of mucociliary function in patients with bronchial asthma.
• To explore the role of chemical mediators in allergic asthma on mucociliary function.
• To identify potential pharmacologic agents for improving mucus transport in asthma.

Main Methods:

• Review of clinical observations of tracheobronchial secretions in asthma patients.
• Analysis of pathologic and functional studies in animal models and human subjects.
• Investigation into the effects of chemical mediators in allergic asthma.
• Identification and evaluation of pharmacologic agents influencing mucous transport rates.

Main Results:

• Evidence suggests impaired mucociliary transport mechanisms in asthma.
• Chemical mediators released in the lung appear to depress mucociliary function in allergic asthma.
• Some pharmacologic agents that increase mucous transport rates have been identified.

Conclusions:

• Abnormal mucociliary function is a significant feature of bronchial asthma.
• Understanding the pathogenesis of impaired mucociliary function is crucial.
• More potent stimulators are likely required for clinical improvement in asthma patients.